Literature DB >> 7002340

ELISA in the diagnosis of Wuchereria bancrofti infection in man: a technique for reducing cross-reactivity.

S Dissanayake, M M Ismail.   

Abstract

The cross-reactivity of filarial heteroantigens, the non-availability of adult Wuchereria bancrofti for antigen extraction, and the lack of structural information on purified filarial heteroantigens make the serological diagnosis of W. bancrofti infection in man a difficult problem. The use of immune sera from cattle infected with Setaria digitata when carrying out the enzyme-linked immunosorbent assay (ELISA) largely eliminated the cross-reactions with serum antibodies generally seen in subjects showing no evidence of W. bancrofti infection.

Entities:  

Mesh:

Year:  1980        PMID: 7002340      PMCID: PMC2395926     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  3 in total

Review 1.  The distribution of human filariasis throughout the world. Part II. Asia.

Authors:  F Hawking
Journal:  Trop Dis Bull       Date:  1976-12

Review 2.  Immunological diagnosis of human filariases: present possibilities, difficulties and limitations.

Authors:  P Ambroise-Thomas
Journal:  Acta Trop       Date:  1974       Impact factor: 3.112

3.  Antigen of Setaria digitata: cross-reaction with surface antigens of Wuchereria bancrofti microfilariae and serum antibodies of W. bancrofti-infected subjects.

Authors:  S Dissanayake; M M Ismail
Journal:  Bull World Health Organ       Date:  1980       Impact factor: 9.408

  3 in total
  2 in total

1.  Antigen of Setaria digitata: cross-reaction with surface antigens of Wuchereria bancrofti microfilariae and serum antibodies of W. bancrofti-infected subjects.

Authors:  S Dissanayake; M M Ismail
Journal:  Bull World Health Organ       Date:  1980       Impact factor: 9.408

2.  Antibody determination in the diagnosis of Wuchereria bancrofti infection in man.

Authors:  S Dissanayake; M M Ismail
Journal:  Bull World Health Organ       Date:  1981       Impact factor: 9.408

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.